COPD includes emphysema and chronic bronchitis, while the broader lung-disease category also covers many other diagnoses. Standard care may include inhaled medications, smoking cessation, vaccination, pulmonary rehabilitation, oxygen when indicated, and specialist monitoring.
Cell and exosome research is exploring inflammation, tissue repair, and lung function, but these approaches remain investigational for COPD and most chronic lung diseases. Carefully monitored clinical trials provide the clearest way to evaluate eligibility and potential benefit.
Patients should continue pulmonology-directed care while exploring research options. Ask what diagnosis and disease stage a proposed therapy is intended for, whether the product and protocol are under FDA oversight, and which lung-function or quality-of-life measures will be followed.
EmCell is a specialized Kyiv cell-therapy center founded in 1994, with clinical and laboratory operations housed in its own facility. Its infrastructure includes a clinical department, a biotechnology laboratory, research and development, PCR testing,…
View Provider